Skip to main content

Table 6 Baseline features of the patients

From: Major adverse cardiac events and mortality in chronic obstructive pulmonary disease following percutaneous coronary intervention: a systematic review and meta-analysis

Studies

Age (yrs)

Males (%)

Ht (%)

Ds (%)

Cs (%)

DM (%)

 

+/−

+/−

+/−

+/−

+/−

+/−

Almagro 2015

67.5/61.6

84.8/76.0

69.7/69.0

66.7/62.0

18.2/17.0

36.4/27.0

Berger 2004

66.1/63.3

56.0/69.0

71.0/70.0

30.0/22.0

30.0/27.0

Campo 2013

70.0/65.0

66.0/74.0

70.0/61.0

46.8/48.3

24.0/27.0

21.8/20.9

Enriquez 2011

66.8/63.2

57.0/66.1

78.1/69.7

67.0/70.0

30.9/24.4

36.9/30.2

Jatene 2016

67.8/63.0

75.6/76.7

74.6/63.6

67.8/63.0

42.4/33.8

24.4/16.8

Konecny 2010

69.9/66.0

72.0/70.0

74.0/70.0

73.0/76.0

30.0/17.0

26.0/24.0

Nishiyama 2009

82.5/70.4

62.5/69.2

43.8/35.7

31.7/39.0

Selvaraj 2005

67.6/64.1

62.0/71.1

75.1/71.6

17.2/20.1

27.0/18.0

37.2/30.5

Sung 2013

68.5/60.9

85.5/81.2

54.8/55.6

39.5/42.3

37.1/34.5

32.3/36.2

Zhang 2012

68.4/64.7

73.0/71.0

75.0/71.0

65.0/63.0

38.0/29.0

25.0/22.0

  1. Abbreviations: yrs. years, Ht hypertension, Ds dyslipidemia, Cs current smoking, DMdiabetes mellitus, ‘+’: COPD ‘-’: no COPD